Allergan navigating choppy waters, as shares rise and fall
March 16, 2018Medical Communications Allergan, Brent Saunders, biotech, drugs, pharma, pharmaceutical
By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative …
Hearing drug failure puts biotech on brink
March 16, 2018Medical Communications, Research and Development Auris, biotech, drugs, pharma, pharmaceutical
Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …
The need for flexible appraisal of rare disease medicines
March 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, feature, pharma, rare disease, rare diseases
Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …
BMS restructure will transfer 90 jobs from NY state to Massachusetts and New Jersey
March 15, 2018Manufacturing and Production BMS, Bristol-Myers Squibb, Massachusetts, New York, new jersey, pharma
Bristol-Myers Squibb has announced plans to relocate around 90 roles from the state of New York to facilities in Massachusetts …
Solid Biosciences rocked by clinical hold, shareholders flee
March 15, 2018Research and Development Solid Biosciences, biotech, drugs, pharma, pharmaceutical
Solid Biosciences raised more than a few eyebrows when it only revealed a partial hold from the FDA stalling its …
Roche appoints new research and early development head
March 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, appointment
Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …
Fat-fighting pharma business files for bankruptcy
March 15, 2018Sales and Marketing Contrave, biotech, drugs, orexigen, pharma, pharmaceutical
Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it …
Andrew Witty takes on a new CEO position
March 15, 2018Medical Communications Andrew Witty, GSK, Optum, UnitedHealth, biotech, drugs, pharma, pharmaceutical
Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …
Top 5 Reasons Why You Should Attend Veeva R&D Summit, Europe
March 15, 2018Medical Communications biotech, drugs, pharma, pharmaceutical, veeva
Veeva R&D Summit, Europe is an annual gathering of pharma, biotech and medical devices professionals in clinical, regulatory, quality, and …
Takeda’s CFO departs forcing company to act
March 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical
Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …
Teva denies wrongdoing in Cephalon pay-to-delay deal hearing
March 14, 2018Research and Development, Sales and Marketing Cephalon, Pay to delay, Provogil, Teva, pay-to-delay, pharma
Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its …
Hammond suggests NHS may receive cash boost
March 14, 2018Medical Communications, Research and Development Autumn Budget, NHS, UK, biotech, drugs, pharma, pharmaceutical
The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …
US “right to try” experimental drug bill defeated in House vote
March 14, 2018Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma
The divisive and much-talked-about “right to try” legislation designed to provide access for terminally ill Americans to experimental and unproven …
World’s first synthetic, non-biologic vaccine developed
March 14, 2018Research and Development Vaccine, biotech, drugs, influenza, pharma, pharmaceutical
One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the …
AbbVie secures further strong results for potential blockbuster
March 13, 2018Research and Development AbbVie, biotech, drugs, elagolix, pharma, pharmaceutical
AbbVie’s elagolix has been slated as a blockbuster-in-the-making by analysts predicting big things for the potential treatment for uterine fibroids …
FDA inspection reveals cGMP issues at Biocon’s major Malaysia facility
March 13, 2018Manufacturing and Production Biocon, CGMP, FDA, pharma
Biocon’s insulin production facility in Johar, Malaysia – the largest integrated insulin manufacturing facility in Asia – has been slapped …
Adaxis-AZ immunotherapy combo hit by clinical hold after death
March 13, 2018Manufacturing and Production, Research and Development Adaxis, AstraZeneca, Imfinzi, biotech, drugs, immunotherapy, pharma, pharmaceutical
Adaxis and AstraZeneca announced that they had agreed a combination program for axalimogene filolisbac and Imfinzi, respectively, back in 2014 …
Anthera pulls the plug on Sollpura after Phase 3 failure, shares plummet 84%
March 13, 2018Manufacturing and Production, Research and Development Anthera, Eli Lilly, Sollpura, pharma, trial failure
Anthera Pharmaceuticals has announced that it is to terminate development of its investigational pancreatic enzyme replacement therapy (PERT) Sollpura after …
Novartis reshuffle begins under new CEO
March 13, 2018Manufacturing and Production, Medical Communications Novartis, biotech, digital, drugs, pharma, pharmaceutical
It’s a common strategy that newly appointed CEOs will try to change the direction of the company via rejigging leadership …
Pfizer begins sell-off, shedding CNS drug to Biogen for $590m
March 13, 2018Manufacturing and Production, Sales and Marketing Biogen, CNS, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer’s decision to back out of the neuroscience space was a strategic move that send shudders through the entire industry, …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
